Literature DB >> 22815342

Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer.

Stephen D Hursting1, Marcie J Hursting.   

Abstract

Nearly 35% of adults and 20% of children in the United States are obese, defined as a body mass index ≥ 30 kg/m(2). Obesity, which is accompanied by metabolic dysregulation often manifesting in the metabolic syndrome, is an established risk factor for many cancers. Within the growth-promoting, proinflammatory environment of the obese state, cross talk between macrophages, adipocytes, and epithelial cells occurs via obesity-associated hormones, cytokines, and other mediators that may enhance cancer risk and progression. This review synthesizes the evidence on key biological mechanisms underlying the obesity-cancer link, with particular emphasis on obesity-associated enhancements in growth factor signaling, inflammation, and vascular integrity processes. These interrelated pathways represent possible mechanistic targets for disrupting the obesity-cancer link.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815342     DOI: 10.1161/ATVBAHA.111.241927

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  58 in total

1.  Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.

Authors:  Kamil Brzóska; Teresa Bartłomiejczyk; Barbara Sochanowicz; Magdalena Cymerman; Jacek Grudny; Jacek Kołakowski; Marcin Kruszewski; Paweł Śliwiński; Kazimierz Roszkowski-Śliż; Lucyna Kapka-Skrzypczak
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

2.  Male predominance in ketosis-prone diabetes mellitus.

Authors:  Xiaohao Wang; Huiwen Tan
Journal:  Biomed Rep       Date:  2015-05-08

3.  Ginsenoside Rg5: Rk1 Exerts an Anti-obesity Effect on 3T3-L1 Cell Line by the Downregulation of PPARγ and CEBPα.

Authors:  Shakina Yesmin Simu; Sungeun Ahn; Veronica Castro-Aceituno; Deok-Chun Yang
Journal:  Iran J Biotechnol       Date:  2017-12-29       Impact factor: 1.671

Review 4.  Minireview: the year in obesity and cancer.

Authors:  Stephen D Hursting
Journal:  Mol Endocrinol       Date:  2012-10-09

5.  Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort.

Authors:  Alexis D Leal; Carrie A Thompson; Alice H Wang; Robert A Vierkant; Thomas M Habermann; Julie A Ross; Ruben A Mesa; Beth A Virnig; James R Cerhan
Journal:  Int J Cancer       Date:  2013-10-15       Impact factor: 7.396

Review 6.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Carolyn Gotay; Andrew Ignaszewski; Andrew D Krahn; Margot K Davis; Christopher Franco; Arya Mani
Journal:  Atherosclerosis       Date:  2017-06-02       Impact factor: 5.162

7.  Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.

Authors:  Wambui G Gathirua-Mwangi; Patrick O Monahan; Mwangi J Murage; Jianjun Zhang
Journal:  Cancer Causes Control       Date:  2017-01-17       Impact factor: 2.506

8.  LPS response pattern of inflammatory adipokines in an in vitro 3T3-L1 murine adipocyte model.

Authors:  Salvatore Chirumbolo; Guido Franceschetti; Elena Zoico; Clara Bambace; Luciano Cominacini; Mauro Zamboni
Journal:  Inflamm Res       Date:  2014-02-14       Impact factor: 4.575

Review 9.  Deconvoluting the obesity and breast cancer link: secretome, soil and seed interactions.

Authors:  Nikki A Ford; Kaylyn L Devlin; Laura M Lashinger; Stephen D Hursting
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-04       Impact factor: 2.673

Review 10.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.